Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
Anthropic Nears $15 Billion Credit Deal Ahead of IPO 
Milei Threatens Falkland Oil Firms With Sanctions 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Xiaomi Shares Jump on Europe EV Expansion Plan 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
Add as a preferred source on Google
Aliso Viejo, CA, Feb. 15, 2018 -- OrthAlign, Inc., a leading provider of orthopedic surgical navigation solutions, is proud to announce a clinical milestone with 75,000 navigation-assisted joint replacement surgeries. OrthAlign’s hand-held sensor-based technologies support a wide array of indications including total knee replacement, partial knee replacement and total hip replacement. The company’s flagship application, KneeAlign® for total knee replacement, provides both tibial and femoral intra-operative navigation in a simple, palm-sized, single-use device.
|
|||
The KneeAlign application is compatible with all standard implant systems. The UniAlign™ application launched in early 2017 leveraging the clinical success of KneeAlign, and allowing for seamless transitions between partial and total knee replacement interventions. In 2017, the Company also introduced HipAlign® for total hip replacement into limited market evaluation. The HipAlign application provides cup navigation and measures changes in leg length and will be fully commercially available in 2018.
“We are thrilled to pass this significant milestone, building and servicing technologies that have assisted surgeons worldwide in completing more than seventy-five thousand successful arthroplasty surgeries,” said Eric Timko, Chairman and CEO of OrthAlign. “In ORs around the world, OrthAlign has become a trusted and reliable tool that our customers depend on to achieve their desired results.”
“What is remarkable about OrthAlign’s technology is that every post-operative result is consistent, every x-ray looks the same,” noted David Mayman, Co-Director of Computer Assisted Surgery at Hospital for Special Surgery. “I’m impressed by the rate of innovation happening at the company right now. The clinical advantage, along with the economics of the single-use disposable model, makes OrthAlign well poised for continued growth.”
ORTHALIGN, INC.
OrthAlign is a privately held medical device and technology company, developing advanced technologies that deliver healthier and more pain-free lifestyles to joint replacement patients, globally. We provide healthcare professionals with cutting edge, computer-assisted surgical tools that seamlessly and cost-effectively deliver vital data and clinical results to optimize outcomes for our patients. For more information regarding OrthAlign, please visit www.orthalign.com or contact Adam Simone ([email protected]).
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3bcf00e9-7096-400c-8f72-674ca85a457d
Adam Simone OrthAlign [email protected]
